Health Research Unit, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Department of Internal Medicine, Hasan Sadikin General Hospital, Bandung, Indonesia.
PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0007183. doi: 10.1371/journal.pntd.0007183. eCollection 2019 Mar.
Distinguishing arboviral infections from bacterial causes of febrile illness is of great importance for clinical management. The Infection Manager System (IMS) is a novel diagnostic algorithm equipped on a Sysmex hematology analyzer that evaluates the host response using novel techniques that quantify cellular activation and cell membrane composition. The aim of this study was to train and validate the IMS to differentiate between arboviral and common bacterial infections in Southeast Asia and compare its performance against C-reactive protein (CRP) and procalcitonin (PCT).
METHODOLOGY/PRINCIPAL FINDINGS: 600 adult Indonesian patients with acute febrile illness were enrolled in a prospective cohort study and analyzed using a structured diagnostic protocol. The IMS was first trained on the first 200 patients and subsequently validated using the complete cohort. A definite infectious etiology could be determined in 190 of 463 evaluable patients (41%), including 89 arboviral infections (81 dengue and 8 chikungunya), 94 bacterial infections (26 murine typhus, 16 salmonellosis, 6 leptospirosis and 46 cosmopolitan bacterial infections), 3 concomitant arboviral-bacterial infections, and 4 malaria infections. The IMS detected inflammation in all but two participants. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the IMS for arboviral infections were 69.7%, 97.9%, 96.9%, and 77.3%, respectively, and for bacterial infections 77.7%, 93.3%, 92.4%, and 79.8%. Inflammation remained unclassified in 19.1% and 22.5% of patients with a proven bacterial or arboviral infection. When cases of unclassified inflammation were grouped in the bacterial etiology group, the NPV for bacterial infection was 95.5%. IMS performed comparable to CRP and outperformed PCT in this cohort.
CONCLUSIONS/SIGNIFICANCE: The IMS is an automated, easy to use, novel diagnostic tool that allows rapid differentiation between common causes of febrile illness in Southeast Asia.
鉴别发热性疾病的病毒感染和细菌病因对临床管理非常重要。感染管理器系统(IMS)是一种新型诊断算法,安装在希森美康血液分析仪上,使用量化细胞激活和细胞膜成分的新技术来评估宿主反应。本研究的目的是训练和验证 IMS 区分东南亚的病毒感染和常见细菌感染,并比较其与 C 反应蛋白(CRP)和降钙素原(PCT)的性能。
方法/主要发现:600 名印度尼西亚成年急性发热患者参加了前瞻性队列研究,并使用结构化诊断方案进行分析。IMS 首先在最初的 200 名患者中进行训练,然后使用完整队列进行验证。在 463 名可评估患者中,有 190 名(41%)确定了明确的感染病因,包括 89 例病毒感染(81 例登革热和 8 例基孔肯雅热)、94 例细菌感染(26 例鼠伤寒、16 例沙门氏菌病、6 例钩端螺旋体病和 46 例世界性细菌感染)、3 例合并的病毒-细菌感染和 4 例疟疾感染。除两名患者外,IMS 检测到所有患者均存在炎症。IMS 对病毒感染的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为 69.7%、97.9%、96.9%和 77.3%,对细菌感染的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为 77.7%、93.3%、92.4%和 79.8%。在有明确细菌或病毒感染的患者中,19.1%和 22.5%的患者炎症仍未分类。当将分类为细菌病因的未分类炎症病例分组时,细菌感染的 NPV 为 95.5%。在本队列中,IMS 的性能与 CRP 相当,优于 PCT。
结论/意义:IMS 是一种自动化、易于使用的新型诊断工具,可快速区分东南亚常见发热性疾病的病因。